Longeveron
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Longeveron and other ETFs, options, and stocks.About LGVN
Longeveron, Inc. is a clinical stage biotechnology company, which engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors.
CEOThan Powell
CEOThan Powell
Employees26
Employees26
HeadquartersMiami, Florida
HeadquartersMiami, Florida
Founded2014
Founded2014
Employees26
Employees26
LGVN Key Statistics
Market cap11.01M
Market cap11.01M
Price-Earnings ratio-0.40
Price-Earnings ratio-0.40
Dividend yield—
Dividend yield—
Average volume410.54K
Average volume410.54K
High today$0.55
High today$0.55
Low today$0.51
Low today$0.51
Open price$0.535
Open price$0.535
Volume437.26K
Volume437.26K
52 Week high$2.24
52 Week high$2.24
52 Week low$0.51
52 Week low$0.51
Stock Snapshot
As of today, Longeveron(LGVN) shares are valued at $0.51. The company's market cap stands at 11.01M, with a P/E ratio of -0.40.
On 2025-12-29, Longeveron(LGVN) stock moved within a range of $0.51 to $0.55. With shares now at $0.51, the stock is trading 0.0% above its intraday low and -7.3% below the session's peak.
Trading volume for Longeveron(LGVN) stock has reached 437.26K, versus its average volume of 410.54K.
The stock's 52-week range extends from a low of $0.51 to a high of $2.24.
The stock's 52-week range extends from a low of $0.51 to a high of $2.24.
People also own
Based on the portfolios of people who own LGVN. This list is generated using Robinhood data, and it’s not a recommendation.